Photoactivable nanoliposomal delivery of minocycline to combat antimicrobial resistance
- 1Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, MA, USA
- 2Division of Health Sciences and Technology, Harvard University and Massachusetts Institute of Technology, Cambridge, MA, 02139, USA
Abstract
Bacterial infections, often originating in localized sites such as wounds, are commonly treated with antibiotics. However, the widespread misuse and overuse of these drugs have led to the alarming rise of antimicrobial resistance (AMR), severely compromising the efficacy of antibiotics. In this context, photodynamic therapy (PDT), together with the resulting light-induced chemical sensitization of the microenvironment — a phenomenon known as photodynamic priming (PDP) — has emerged as a promising strategy to overcome bacterial resistance mechanisms. Upon light activation in the presence of a photosensitizer, PDT induces multiple disruptive effects in resistant bacteria, including enhanced membrane permeability, efflux pump inhibition, and inactivation of drug-modifying enzymes, thereby restoring antibiotic susceptibility. PDT can synergize with antibiotics by enhancing antimicrobial efficacy. However, in most cases, these treatments are delivered sequentially. Effective implementation of this approach requires the simultaneous delivery of both antibiotics and photosensitizers at optimized ratios directly to the site of infection, a challenge for free drugs due to their disparate pharmacokinetic profiles. Here, we introduce photoactivatable liposomes for antibiotic delivery (PLA), a light-responsive nanoplatform that co-encapsulates the antibiotic minocycline and the photosensitizer benzoporphyrin derivative to enable intracellular co-delivery at synergistic ratios. We demonstrate the versatility of the PLA synthesis, its physicochemical stability, and its enhanced phototoxic performance against antibiotic-resistant bacterial strains.
Related
- Reimagining Antimicrobial Drug Delivery: Spatiotemporally Adaptive Therapeutics for Biofilm-Associated Infections and Antimicrobial Resistance.
- Cross-kingdom antimicrobial resistance profiling: A unified multiplex PCR assay for simultaneous bacterial and fungal detection
- Beliefs and Behaviours related to Antibiotic Use and Antimicrobial Resistance in Poland: General Population Survey
- Artificial Intelligence in Rapid Diagnostics for Antimicrobial Resistance: From Bench to Bedside
- In Ovo Exposure to Phenanthrene Promotes Antimicrobial Resistance Genes and Hemolysin Virulence Factor in Guts of Chicken Embryos
BibTeX
@article{quilezalburquerque2026photoactivable,
title = {{Photoactivable nanoliposomal delivery of minocycline to combat antimicrobial resistance}},
author = {Jose Quílez–Alburquerque and Fernanda Viana Cabral and Yanfang Feng and Tayyaba Hasan},
journal = {Journal of drug delivery science and technology},
year = {2026},
month = jul,
doi = {10.1016/j.jddst.2026.108724},
url = {https://doi.org/10.1016/j.jddst.2026.108724},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Photoactivable nanoliposomal delivery of minocycline to combat antimicrobial resistance
AU - Jose Quílez–Alburquerque
AU - Fernanda Viana Cabral
AU - Yanfang Feng
AU - Tayyaba Hasan
PY - 2026
DA - 2026/07/16
JO - Journal of drug delivery science and technology
DO - 10.1016/j.jddst.2026.108724
UR - https://doi.org/10.1016/j.jddst.2026.108724
AB - Bacterial infections, often originating in localized sites such as wounds, are commonly treated with antibiotics. However, the widespread misuse and overuse of these drugs have led to the alarming rise of antimicrobial resistance (AMR), severely compromising the efficacy of antibiotics. In this context, photodynamic therapy (PDT), together with the resulting light-induced chemical sensitization of the microenvironment — a phenomenon known as photodynamic priming (PDP) — has emerged as a promising strategy to overcome bacterial resistance mechanisms. Upon light activation in the presence of a photosensitizer, PDT induces multiple disruptive effects in resistant bacteria, including enhanced membrane permeability, efflux pump inhibition, and inactivation of drug-modifying enzymes, thereby restoring antibiotic susceptibility. PDT can synergize with antibiotics by enhancing antimicrobial efficacy. However, in most cases, these treatments are delivered sequentially. Effective implementation of this approach requires the simultaneous delivery of both antibiotics and photosensitizers at optimized ratios directly to the site of infection, a challenge for free drugs due to their disparate pharmacokinetic profiles. Here, we introduce photoactivatable liposomes for antibiotic delivery (PLA), a light-responsive nanoplatform that co-encapsulates the antibiotic minocycline and the photosensitizer benzoporphyrin derivative to enable intracellular co-delivery at synergistic ratios. We demonstrate the versatility of the PLA synthesis, its physicochemical stability, and its enhanced phototoxic performance against antibiotic-resistant bacterial strains.
SN - 1773-2247
SN - 2588-8943
ER -